Literature DB >> 15538601

SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder.

Eduard Maron1, Jyrki T Kuikka, Kai Ulst, Jari Tiihonen, Veiko Vasar, Jakov Shlik.   

Abstract

The purpose of this study was to characterize the binding properties of serotonin transporter (5-HTT) in the brain of the patients with generalized anxiety disorder (GAD) in comparison to healthy subjects using single photon emission computer tomography (SPECT) with the radioligand [123I]nor-beta-CIT. The subjects were 7 patients with GAD and 7 matched healthy volunteers. The regions of interest (ROI) were the midbrain and the thalamus. The comparison of the volumes of distribution did not show significant differences between the patients and controls in the binding of nor-beta-CIT to 5-HTT in the ROI. Binding of 5-HTT in the midbrain of patients was significantly and negatively correlated with their anxiety levels measured by the visual analogue scale immediately before the first scan (r=-0.79, p=0.035). This study failed to demonstrate an altered functional activity of 5-HTT in patients with GAD when compared with controls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538601     DOI: 10.1007/s00406-004-0520-3

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  24 in total

1.  5-HT and mechanisms of defence.

Authors:  J F Deakin; F G Graeff
Journal:  J Psychopharmacol       Date:  1991-01       Impact factor: 4.153

2.  Evidence for genetic influences common and specific to symptoms of generalized anxiety and panic.

Authors:  J F Scherrer; W R True; H Xian; M J Lyons; S A Eisen; J Goldberg; N Lin; M T Tsuang
Journal:  J Affect Disord       Date:  2000 Jan-Mar       Impact factor: 4.839

3.  A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

Authors:  A Heinz; D W Jones; C Mazzanti; D Goldman; P Ragan; D Hommer; M Linnoila; D R Weinberger
Journal:  Biol Psychiatry       Date:  2000-04-01       Impact factor: 13.382

4.  Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.

Authors:  D S Charney; S W Woods; W K Goodman; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

6.  Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder.

Authors:  J A den Boer; H G Westenberg
Journal:  Psychiatry Res       Date:  1990-03       Impact factor: 3.222

Review 7.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 9.  Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression.

Authors:  J K Staley; R T Malison; R B Innis
Journal:  Biol Psychiatry       Date:  1998-10-01       Impact factor: 13.382

10.  Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder.

Authors:  M Germine; A W Goddard; S W Woods; D S Charney; G R Heninger
Journal:  Biol Psychiatry       Date:  1992-09-01       Impact factor: 13.382

View more
  7 in total

1.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

2.  Alterations in white matter volume and its correlation with clinical characteristics in patients with generalized anxiety disorder.

Authors:  Chung-Man Moon; Gwang-Woo Jeong
Journal:  Neuroradiology       Date:  2015-08-21       Impact factor: 2.804

Review 3.  The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology.

Authors:  Elizabeth I Martin; Kerry J Ressler; Elisabeth Binder; Charles B Nemeroff
Journal:  Psychiatr Clin North Am       Date:  2009-09

Review 4.  5-HT radioligands for human brain imaging with PET and SPECT.

Authors:  Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen
Journal:  Med Res Rev       Date:  2011-06-14       Impact factor: 12.944

Review 5.  Serotonin and mental disorders: a concise review on molecular neuroimaging evidence.

Authors:  Shih-Hsien Lin; Lan-Ting Lee; Yen Kuang Yang
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-12-26       Impact factor: 2.582

Review 6.  Biological markers of generalized anxiety disorder.

Authors:  Eduard Maron; David Nutt
Journal:  Dialogues Clin Neurosci       Date:  2017-06       Impact factor: 5.986

7.  Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder.

Authors:  K R Müller-Vahl; N Szejko; F Wilke; E Jakubovski; L Geworski; F Bengel; G Berding
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.